New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

The brain’s map of the body remains largely unaffected by amputation, potentially informing phantom limb pain management and ...

New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...

Advances in neovascular macular degeneration, presented at ASRS 2025, include efficacy of aflibercept 8 mg as well as ...

A UK study shows that ADHD in young women increased during the COVID-19 pandemic, peaking in the age group 20-24 years; ...

Recently, second-generation anti-VEGF agents, including brolucizumab, faricimab, and 8 mg aflibercept, have become available ...

A deep-learning analysis of three-dimensional optical coherence tomography scans shows promising accuracy in distinguishing ...

The American College of Obstetricians and Gynecologists (ACOG) has issued new guidelines on deferred umbilical cord clamping ...

About 23% of MRI scans of the hand or wrist may reveal an incidental finding, and only about 3% overall may need further ...

Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

The FDA has approved brensocatib tablets in 10-mg and 25-mg doses as once-daily treatment for non-cystic fibrosis ...

In nine studies (76 patients), the anti-IgE monoclonal antibody omalizumab (Xolair), given every 2-4 weeks at doses ranging ...